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Abstract
Caffeine has been demonstrated to enhance olfactory function in rodents, but to date, the sparse research in humans has not
shown any equivalent effects. However, due to the methodological nature of those human studies, a number of questions remain
unanswered, which the present study aimed to investigate. Using a double-blind experimental design, participants (n = 40)
completed baseline moodmeasures, standardised threshold and identification tests and were then randomly allocated to receive a
capsule containing either 100 mg of caffeine or placebo, followed by the same olfactory tests and mood measures. Results
revealed that despite a trend toward elevated arousal following caffeine for habitual caffeine consumers, there were no changes in
odour function. In contrast, for non-caffeine consumers, caffeine acted to enhance odour (threshold) sensitivity but reduce odour
identification. Overall, these findings demonstrate a complex profile of effects of caffeine on odour function and, given the
evidence from the wider caffeine literature, it is proposed that the effects of caffeine might be limited to older populations.
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Introduction
Caffeine is contained in a number of common beverages such
as tea, coffee and energy drinks and has been consumed for
over 2000 years (Barone and Roberts 1984). Caffeine is clas-
sified as a psychostimulant and has been extensively
researched for its effects over the years, which include in-
creases in arousal and enhanced performance in tasks requir-
ing vigilance (see review Temple et al. 2017). However, there
is still debate on the veracity of such effects in those who
regularly consume caffeine, i.e. are the observed effects more
about reversing the withdrawal symptoms of caffeine (James
and Rogers 2005). At doses routinely consumed by humans,
the main mechanisms of action are the antagonism of adeno-
sine receptors (Patocka et al. 2019) and of particular interest
here are its effects on the adenosine A2a receptors. Research
has shown that the stimulatory effects of caffeine are largely
achieved via the blockage of adenosine A2a receptors
(Svenningsson et al. 1999), and separately, we know that
A2a receptors are found in the olfactory bulb (Kaelin-Lang
et al. 1999). Evidence for the link between adenosine and
odour function was also demonstrated in an elegant rodent
experiment where both caffeine and separately an A2a receptor
antagonist enhanced olfactory function (Prediger et al. 2005).
Since no effects were found for an adenosine A1 receptor
antagonist, that study suggested that the enhancements ob-
served were due to caffeine’s action as a partial A2a receptor
antagonist.
Due to the importance of our sense of smell (Stevenson
2010; Philpott and Boak 2014) and the ineffectiveness of in-
terventions for anosmic/hyposmic individuals (Philpott and
Boak 2014; Lill et al. 2006), there is growing interest in the
possibility that caffeine might have positive effects on olfac-
tion in humans. This has also been bolstered by one study that
found that in humans with first-degree relatives of Parkinson’s
disease patients, olfactory function was higher for those who
consumed more caffeine (Siderowf et al. 2007). To date, only
two studies have tested the effects of caffeine on olfactory
function in humans, where one study found that caffeine ad-
ministration had no effect on a group of hyposmic (impaired
sense of smell) individuals (Meusel et al. 2016). The second
study tested individuals without any known smell impair-
ments and despite caffeine improving attention (fewer errors),
there were no differences on odour function (Han et al. 2020).
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Though these two studies suggest that caffeine has no
effect on odour function, there are however some aspects
that remain unclear. Both of the previous studies used coffee
(caffeinated versus decaffeinated) as the method of adminis-
tering caffeine, which, although having high ecological va-
lidity, does also introduce issues in terms of the additional
active compounds found in coffee (Arnaud 2011) and hence
does not answer the question of whether caffeine alone
might influence odour function. It is also likely that there
would be expectancy effects from individuals receiving such
beverages (both caffeinated/decaffeinated) which may have
affected subsequent behaviour and have been found in caf-
feine research (e.g. Dawkins et al. 2011). Additionally, both
of those studies used a relatively modest and similar dose of
caffeine, estimated at 65 mg (Meusel et al. 2016) and 72 mg
(Han et al. 2020), and it is therefore unclear whether a larger
dose might yield any differences in odour function. Finally,
neither of the studies measured individual mood and hence it
was uncertain whether the stimulant effects of caffeine were
present. To answer these questions, the current experiment
examined the effects of a dose of caffeine (100 mg) shown
to havemood effects (e.g. Smit and Rogers 2000; Stafford and
Yeomans 2005) on odour function and mood in a healthy
sample. We also took measures of caffeine craving (West
and Roderique-Davies 2008) to verify whether individuals
who were overnight deprived of caffeine differed in the sub-




Participants (n = 40; ageM = 19.3, SD = 1.9 years, range 18–
29; 34 females, 6 males) were university students. Sample size
(N = 40) was predetermined by a combination of power anal-
ysis calculations and previous work in this area. Power anal-
ysis (G*Power 3.1) for ANOVA, given f = 0.50, power 0.8
and α = 0.05, recommends N = 34 participants, but we opted
for a more cautious N = 40. Effect size was based on a previ-
ous work testing olfactory function (Stafford and Welbeck
2010; Stafford et al. 2019). Participants were advised not to
take part if they had respiratory problems (e.g. asthma): prob-
lems in their ability to smell and/or allergies to certain
odourants. Additionally, due to the administration of caffeine,
we specified that individuals with any known aversions to
food additives (aspartame, saccharin, fructose, glucose, su-
crose, caffeine, natural food colouring, maltodextrin) should
not take part. The study was advertised as ‘Understanding our
sense of smell’, and the protocol (see Table 1) was given
ethical approval from the University’s Science Faculty
Ethics committee (SFEC 2018-095); all participants gave in-
formed consent.
Design
The study used a between-subjects design, where individuals
were randomly assigned to a caffeine or placebo condition and
the main dependent variables were odour sensitivity (thresh-
old), odour identification and mood.
Olfactory threshold
The odour used for the threshold test was n-butanol (Fisher
Scientific, UK) which was diluted in distilled water. The
odourant was prepared using fifteen 50-ml amber glass bot-
tles, in 16 dilution steps, starting at 1% (step 1) with each
successive step diluted by a factor of two using serial dilution
to the lowest (step 16). In addition to the odour containing
bottles, for each dilution step, two ‘blank’ bottles (containing
dilutant only) were used in the threshold test. Testing com-
menced by asking participants to smell the bottle with the
highest concentration to familiarise themselves with the target
odour. They were then presented with the triplet containing
the weakest concentration. Following presentation of the last
bottle of the triplet (counterbalanced), participants were asked
which bottle contained the odour (1, 2 or 3). If the participant
answered correctly (and it was the lowest concentration), they
were presented with the same triplet again (in a different or-
der) and the task repeated until they made a mistake, which
resulted in the triplet containing the next concentration step
being presented. Using a single up-down staircase system (as
used widely in olfactory research, e.g. (Kobal et al. 1996;
Hummel et al. 2007)), this was then repeated until there were
seven ‘turning points’, with the mean of the last four points
determining the threshold for the individual. Each bottle was
held under the participant’s nose (≈ 2 cm) and gently waved
Table 1 Timeline representing flow of experiment
Task Minutes pre/post treatment
POMS (1) − 30
Odour threshold (1) − 25
Odour identification (1) − 10
Treatment—capsule 0
POMS (2) 30
Odour threshold (2) 35
Odour identification (2) 50
Caffeine craving (QCC) 60
General health form 65
Participant question form 67
Finish 70
POMS Profile of Mood States, QCC Questionnaire of Caffeine Craving
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between each nostril to ensure optimal inhalation. A blindfold
was used by the participants to avoid odour identification. The
experimenter wore cotton gloves (Boots, Portsmouth) to re-
duce any cross contamination of odours.
Odour identification
This task was closely modelled on the Sniffin’ sticks identifi-
cation test (Hummel et al. 2007). In this version, we used
fifteen different odourants: lavender (Essential oil, Holland
and Barret, 3 drops), glue (PVA, 3 drops), sandalwood
(Essential oil, Mia Roma, 3 drops), nutmeg (Tesco, small
section), oil (WD40, 1 spray), vanilla extract (Tesco, 3 drops),
star anise (Tesco, small section), cinnamon (Schwartz, 1 ml),
pear (isoamyl acetate, Fisher Scientific, 1 ml), tea leaves
(Tesco, 2 ml), chocolate (Dale Air, 1 ml), thyme
(Sainsburys, 2 ml), frankincense (essential oil, Holland and
Barret, 3 drops), caraway (Tesco) and oregano (Tesco, 2
ml). For each odourant, the respective amount was placed on
a cotton ball (Boots) if a liquid or under the cotton ball; all
odourants were then placed in an individual amber glass bottle
(50 ml). Participants were presented with one odour at a time
and asked to identify which odour they had smelled from a
form consisting of four possible odours. They were instructed
to make a choice even if they were unsure or did not detect an
odour. To minimize practice effects, there were two different
versions of the task, which varied in the order the odours were
presented and also in the order the odours appeared on the
form.We completed piloting of the test to ensure performance
was neither at floor or ceiling levels.
Profile of Mood States
We used a briefer version composed of the original 72-item
Profile of Mood States (POMS) questionnaire (McNair et al.
1971), which composed of 39 items from the original inven-
tory, with the addition of ‘jittery/nervous/shaky’, ‘headache’,
‘hungry’ and ‘calm’, which were included to measure with-
drawal and general effects of caffeine. The rationale for using
a shorter version was based on the premise that a number of
factors were not relevant to caffeine research, i.e. ‘Anger’,
‘Depression’ and ‘Elated’, and was used in previous work
(Stafford and Yeomans 2005). Subjects rated the 43 items
on a 5-point scale from ‘Not at all’ to ‘Extremely’. From these
responses, POMS permits five factors to be extracted: ‘anxi-
ety’, ‘fatigue’, ‘vigour’, ‘confusion’ and ‘friendliness’ and the
additional factor of ‘arousal’ (anxiety + vigour) − (fatigue +
confusion).
Caffeine Craving Questionnaire
The current study used the Questionnaire of Caffeine Craving
(QCC; West and Roderique-Davies 2008) which was based
on the Questionnaire of Smoking Urges (QSU) (Tiffany and
Drobes 1991). The QCC is a 21-item measure, yielding three
factors: factor 1 (Desires and intention), factor 2 (General
reinforcement) and factor 3 (Negative reinforcement).
General Health Questionnaire
This form contained of five questions concerning the frequen-
cy of consuming tea, coffee and soft drinks which was used in
previous work (Stafford et al. 2010), followed by the frequen-
cy of smoking/vaping and alcohol consumption.
Caffeine administration
Pre-weighed quantities of caffeine hydrochloride and a white
powder used as a placebo (maltodextrin) were stored in small
transparent non-gelatine vegetarian capsules (all items sup-
plied by Bulk Powders UK) (size 4) in coded plastic boxes
to ensure double-blind testing. The quantity of caffeine/
placebo was 100 mg.
Procedure
Participants were instructed to refrain from consuming any
food/drinks that contained the following substances, alcohol,
taurine, caffeine, glucose and aspartame, for 12 h before their
allocated session. On arrival, participants were asked what
they had consumed in the last 12 h and any participants who
had consumed any of the listed substances were rescheduled
to another session; they then completed baseline measures
(POMS, odour threshold, odour identification). They were
then given the capsule with a glass of water. This was follow-
ed by a rest period (30 min) to allow for the caffeine to be
metabolised. Next, they completed the same tasks in the same
order; the version for the odour identification task was differ-
ent to the first presentation. Following the completion of these
tasks, they completed the QCC, general health form and were
asked two questions: (a) What did they think was the aim of
the study? (b) Did they think the capsule they consumed
contained caffeine: Y/N? Finally, they were given a full
debriefing.
Data analyses
Preliminary analyses revealed that one participant did not
achieve a threshold score, even at the highest concentration
and was therefore excluded from further analyses.
Sample characteristics (Table 2) showed that some partic-
ipants (n = 8) were not habitual caffeine consumers, and al-
though this was not a primary aim of the study, we decided to
allocate these participants to a Non-consumer group to com-
pare against Consumers. There were an equal number (n =
4/4) of participants in the caffeine and placebo conditions,
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and there were no differences in age in any of the
(Condition—Caffeine/Placebo and Group—Consumer/Non-
consumer) comparisons. Gender was evenly spread in the
Condition/Group combinations (Table 2).
Data for odour threshold, odour identification and mood
were calculated as differences from baseline. These data were
then analysed using a multivariate ANOVA, with the
between-subjects factors of Condition (Caffeine/Placebo)
and Caffeine status (Consumer/Non-consumer). Caffeine
craving data was also analysed with the same multivariate
ANOVA. Preliminary analyses of the data revealed that
Box’s Test of Equality of Covariance Matrices was violated,
Box’s M = 53.25, F = 1.99, p = .009, which was due to
differences in variability in the Non-consumer group, particu-
larly in the Desires and intention factor.
Results
Odour threshold
Analyses revealed no significant main effect of Condition,
F(1,35) = 0.27, ns, with sensitivity increasing across both
the caffeine and placebo conditions (Table 2). There was,
however, a main effect of Group, F(1,35) = 4.63, p = .038,
η2 = .12, qualified by a Condition ×Group interaction, F(1,35)
= 4.53, p = .04, η2 = .12. Further analyses revealed that there
were no differences between caffeine consumers and non-
consumers following placebo (p = .99), but in contrast for
caffeine, the non-consumers sensitivity was higher than the
consumers (p = .016) (Fig. 1).
Odour identification
For odour identification, the main effect of Condition was not
significant F(1,35) = 3.72, p = .06, though interestingly, there
was a trend toward poorer performance following caffeine (M
= − 1.13, SD = 1.76) compared with placebo (M = 0.03, SD =
1.34). The main effect of Group was not significant, F(1,35) =
0.06, ns, but there was a significant Condition × Group inter-
action, F(1,35) = 6.90, p = .01, η2 = .17. Further analyses
demonstrated this to be due to no differences of Condition
for caffeine consumers (p = .39), whereas for non-consumers,
caffeine led to poorer performance compared with placebo (p
= .059) (Fig. 2; Table 3).
Mood
The analyses revealed no main effects of Condition on any of
the mood measures (all F’s < 1.3); however, when analysed
separately for each group, differences did emerge. For
Consumers only, arousal ratings increased for those receiving
caffeine but declined for those in the placebo group, F(1,29) =
3.03, p = .09, η2 = .09. Tense/anxiety ratings declined more
sharply for placebo compared with caffeine, F(1,29) = 3.64, p
= .06, η2 = .11 (Table 3). The mood data therefore show non-
significant trends for the stimulant effects of caffeine in caf-
feine consumers but not in non-consumers.
Caffeine craving
Craving measures showed a main effect of Group for Desires
and intention, F(1,35) = 8.25, p = .007, η2 = .19 and General
reinforcement, F(1,35) = 9.71, p = .004, η2 = .22 where, un-
surprisingly, craving was higher for consumers versus non-
consumers (Table 3). There were no effects for Condition
(all F’s < 1), but there was a significant Condition × Group
interaction for Negative reinforcement, F(1,35) = 5.16, p =
Table 2 Mean (SD) participant characteristics by Condition (Caffeine/Placebo)
Caffeine Placebo
Age 19.0 ± 1.0 19.6 ± 2.5
Gender (F/M) 18/2 16/4
Number of non-habitual caffeine consumers 4 4
Gender (F/M) 4/0 3/1
Caffeine (mg per day*) 223.1 ±152.2 171.6 ±72.7

















Fig. 1 Mean odour threshold by condition (Caffeine/Placebo) and Group
(Consumer/Non-consumer)
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.02, η2 = .13, with further analyses showing that for
Consumers only, ratings were higher following caffeine com-
pared with placebo.
Discussion
The study found that, overall, there were no significant effects
of caffeine on odour threshold or identification, which is con-
sistent with previous work (Meusel et al. 2016; Han et al.
2020).
Both of those studies utilized coffee as the vehicle for de-
livering caffeine and since coffee also contains other active
compounds (Arnaud 2011); the effects of caffeine alone on
odour function were unknown. By using pure caffeine
contained in capsules, the current study was able to overcome
that limitation and additionally examine the effects of using a
larger dose of caffeine. The findings here suggest that neither
coffee containing caffeine nor caffeine alone have any overall
effect on odour function. Interestingly, however, there were
differences between habitual caffeine consumers and non-
consumers which were not investigated in the earlier work
(Meusel et al. 2016; Han et al. 2020). For non-consumers
only, caffeine had divergent effects, leading to higher odour
sensitivity (threshold test) compared with consumers but, in
contrast, reduced odour identification. In trying to account for
these differences, it could be that the stimulatory effects of
caffeine were particularly beneficial for the threshold test, be-
ing a task longer in duration and possiblymonotonous to some
individuals, whereas the same arousing effects were not ben-
eficial in the identification test, being a shorter task, demand-
ing higher order cognitive function. This theory would also
seem to fit the pattern that caffeine has a more reliable effect
on attention and vigilance rather than memory and more de-
manding cognitive tasks (Stafford et al. 2007).
The reason that consumers’ odour function did not follow
the same pattern could be explained in that they would be less
sensitive to the effects of caffeine, and therefore, following a
period of caffeine abstinence, consumer ingestion of caffeine
may have simply reversed caffeine withdrawal (James and
Rogers 2005). Nevertheless, it was curious that the best evi-
dence of any changes in mood was for the consumers only, in
terms of tense and arousal, though only reaching significance
in the former. Such differences do however link to the wider
caffeine literature which has shown differences in the effects
of caffeine in consumers and non-consumers. For instance,
one study found that caffeine benefitted performance
(vigilance) more in non-consumers versus consumers but in
contrast for mood, consumers derived more benefit from caf-
feine than non-consumers (Haskell et al. 2005). Drawing on
these separate areas, it could be, therefore, that any caffeine-
induced alterations in odour function are not dependent on
observable changes in mood.
The absence of caffeine effects on olfaction needs to be
considered in the wider context. Previous human work that
suggested positive effects was based on first-degree relatives
of Parkinson’s disease patients, where increasing lifetime es-
timates of caffeine intake were associated with higher olfac-
tory (UPSIT) function (Siderowf et al. 2007). One obvious
Table 3 Mean (SD) odour function, cravings and mood by Condition (Caffeine/Placebo) and Group (Consumer/Non-consumer)
Caffeine Placebo
Consumers Non-consumers Consumers Non-consumers
Threshold score* 0.13 ± 1.7 3.06 ± 2.75 1.24 ± 1.57 1.25 ± 1.10
Identification − 0.27 ± 1.53 − 2.0 ± 2.0 − 0.69 ± 1.45 0.75 ± 1.25
Tense/anxiety − 0.67 ± 2.79 0.00 ± 3.36 − 1.94 ± 2.67 2.23 ± 3.09
Arousal 2.67 ± 6.98 2.75 ± 5.38 − 1.31 ± 5.72 4.00 ± 2.16
Craving:
Desires and intention 2.68 ± 1.43 1.21 ± 0.26 2.21 ± 1.03 1.11 ± 0.17
Gen reinforcement 4.71 ± 1.17 3.35 ± 1.22 4.70 ± 1.17 3.0 ± 1.34
Neg reinforcement 3.92 ± 1.55 1.80 ± 0.63 2.84 ± 1.23 3.20 ± 1.72

















Consumers      Non-consumers        Consumers            Non-consumers 
Caffeine                                            Placebo
Fig. 2 Mean odour identification by Condition (Caffeine/Placebo) and
Group (Consumer/Non-consumer)
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difference between that work and the study here is that no
caffeine was administered in that study but rather relied on
individuals’ account of routine caffeine intake. It is also worth
noting that the participants in that study were all over 50 years
of age and hence substantially older than the study here (M =
19 years) and the previous study in normosmics (27 years;
Han et al. 2020). This fact could be important in that the
enhancing effects of caffeine on olfaction in animal work were
based on older (12 and 18 months) rodents (Prediger et al.
2005) and therefore suggest that the beneficial effects of caf-
feine on odour function might be restricted to older humans.
The suggestion from that work was that the age-related in-
crease in adenosine A2a receptors may play a role in declining
odour function, which can be temporarily reversed by caf-
feine’s antagonism of those adenosine A2a receptors. One of
the consequences of this blockade is the increasing transmis-
sion of a range of neurotransmitters including dopamine, nor-
adrenaline, and glutamate in brain areas related to cognitive
function (see review, Patocka et al. 2019). In summary, in
accordance with the wider research on the effects of caffeine
in ageing (e.g. VanGelder et al. 2007), it could be that caffeine
may influence olfactory function but that this is mainly limited
to older individuals.
In terms of the study limitations, it is important to acknowl-
edge that whilst the overall sample size used in this study was
adequate in terms of the pre study power calculations, the
number of non-consumers in this study (n = 8) was rather
small and therefore the findings relating to that group need
to be treated as preliminary. It is also worth reflecting that
although the dose of caffeine used here was larger than previ-
ous work on odour function (Meusel et al. 2016; Han et al.
2020), it is uncertain whether using a larger dose may lead to
different effects, which given caffeine’s rather inconsistent
effects (Stafford 2004; Stafford et al. 2007), would be worth
examination. Finally, the odour ‘identification’ test used in
this study was a custom-built test, used for the first time, and
even though modelled closely on the Sniffin’ sticks identifi-
cation test (Kobal et al. 1996), it was not a validated test (see
considerations, Hsieh et al. 2017). Nevertheless, we did com-
plete pilot testing before the study to ensure that the test was
sensitive to detect effects and performance was not at ‘floor’
or ‘ceiling’ levels.
In conclusion, we found no overall effect of caffeine on
odour function, but in evidence that for non-consumers only,
caffeine had beneficial effects on odour threshold but im-
paired odour identification.
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